Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Completes Lomb Acquisition

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it has completed the acquisition of Lomb Scientific, a provider of lab chemicals, consumables, and instruments in Australia and New Zealand, for an undisclosed sum.

Lomb Scientific, which will be integrated into Thermo Fisher's Laboratory Products and Services and Analytical Technologies segments, had revenues in 2009 of A$34 million ($32.8 million), and it has around 100 employees.

The deal was initially announced at the beginning of December.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.